News tagged with malignant cells
Drugs targeting chromosomal instability may fight a particular breast cancer subtype
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of ...
Feb 06, 2012 |
5 / 5 (1) |
0
|
A thought-provoking new therapeutic target for brain cancer?
Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant ...
Feb 01, 2012 |
not rated yet |
0
Project to improve radiotherapy planning
A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. ...
Jan 30, 2012 |
not rated yet |
0
Cell-CT: A new dimension in breast cancer research
Despite advances in both the diagnosis and treatment of breast cancer, the disease remains a leading worldwide health concern.
Jan 05, 2012 |
5 / 5 (2) |
0
|
Novel export-inhibitor shows promise for treating chronic lymphocytic leukemia
An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies, ...
Dec 12, 2011 |
5 / 5 (2) |
0
Suppression of protein critical to cell division stops cancer cells from dividing, kills them
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly, ...
Dec 09, 2011 |
5 / 5 (8) |
0
|
MRI may be noninvasive method to measure breast cancer prognosis
Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients ...
Dec 08, 2011 |
not rated yet |
0
Nipping metastases in the bud: A novel strategy for fighting cancer targets secondary tumors
The proliferation of metastases is often the main cause of complications and death from cancer. For the first time, researchers are looking very closely at the development of these metastases themselves, instead ...
Dec 07, 2011 |
not rated yet |
0
|
Protein associated with childhood cancer alters the structure of DNA, leading to cancer
UNC scientists have demonstrated for the first time how a critical gene associated with a type of childhood cancer alters the way DNA is packaged in cells and leads to cancer. Their laboratory discovery could result in the ...
Nov 18, 2011 |
not rated yet |
0
|
Dendritic cells control lymphocyte entry into lymph nodes
Dendritic cells, discovered in 1973 by Ralph Steinman (2011 Nobel prize in Physiology or Medicine) and known for their role as sentinels of the immune system, have an essential function in the development ...
Nov 17, 2011 |
5 / 5 (1) |
0
Researchers unravel biochemical factor important in tumor metastasis
A protein called "fascin" appears to play a critical transformation role in TGF beta mediated tumor metastasis, say researchers at Moffitt Cancer Center in Tampa, Fla., who published a study in a recent issue of the Journal of ...
Nov 09, 2011 |
not rated yet |
0
Using Viagra to combat malignant melanoma
Many tumors cause chronic inflammations, which, in their turn, suppress specific attacks against the tumor by the immune system. Scientists at the German Cancer Research Center and Medical Faculty Mannheim ...
Nov 08, 2011 |
5 / 5 (1) |
0
|
A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.
Oct 25, 2011 |
not rated yet |
0
|
Researchers find coupling of proteins promotes glioblastoma development
Two previously unassociated proteins known to be overly active in a variety of cancers bind together to ignite and sustain malignant brain tumors, a research team led by scientists at The University of Texas MD Anderson Cancer ...
Oct 21, 2011 |
not rated yet |
0
|
Feed a cold -- starve a tumor
The condition tuberous sclerosis, due to mutation in one of two tumor suppressor genes, TSC1 or TSC2, causes the growth of non-malignant tumors throughout the body and skin. These tumors can be unsightly and cause serious ...
Oct 21, 2011 |
not rated yet |
0
Malignancy
Malignancy (from the Latin roots mal- = "bad" and -genus = "born") is the tendency of a medical condition, especially tumors to become progressively worse and to potentially result in death. It is characterized by the properties of anaplasia, invasiveness, and metastasis. Malignant is a corresponding adjectival medical term used to describe a severe and progressively worsening disease. The term is most familiar as a description of cancer. A malignant tumor may be contrasted with a non-cancerous benign tumor in that a malignancy is not self-limited in its growth, is capable of invading into adjacent tissues, and may be capable of spreading to distant tissues (metastasizing), while a benign tumor has none of those properties. Malignant tumor is synonymous with cancer. Uses of "malignant" in oncology:
Non-oncologic disorders referred to as "malignant":
For more information about Malignancy, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
